How has Summit Therapeutics's warrants and rights outstanding changed year-over-year?

Summit Therapeutics's warrants and rights outstanding decreased by 100.0% year-over-year, from 1M to 0.

What is the long-term trend for Summit Therapeutics's warrants and rights outstanding?

Over 2 years (2023 to 2025), Summit Therapeutics's warrants and rights outstanding has grown at a -100.0% compound annual growth rate (CAGR), from 5M to 0.

Summit Therapeutics SMMT Warrants and Rights Outstanding

Warrants and Rights Outstanding at other companies

Joby AviationJOBY

$29.46M-51.9%

Jaguar Uranium JAGU

1—

NexPoint Real Estate FinanceNREF

$136.74M+221%

Jaguar Uranium JAGU

1—

Jaguar Uranium JAGU

3—

Jaguar Uranium JAGU

70K—

Other financials

Income statement

See full

Revenue-—

Operating income-$65.6M-81.2%

Net income-$189.4M-201%

EPS (diluted)-$0.24-167%

Balance sheet

See full

Cash & equivalents$8.2M+7.2%

Total debt$20.0M+211%

Total equity$545.9M+58.5%

Total assets$647.9M+68.8%

Cash flow

See full

Operating cash flow-$122.3M-99.9%

CapEx$245.0K-41.9%

Free cash flow-$122.5M-99.0%

Valuation

See full

Market cap$10.67B+3.3%

Enterprise value$10.68B+3.4%

Profitability

See full

Operating margin-268,266.8%-272,316pp

Net margin-271,685%-275,966pp

FCF margin-5,931.6%+4,730pp

Returns & leverage

See full

Return on equity-271%-1,725pp

Debt / equity0×0.0×

Current ratio7.4×-3.2×

Where this comes from

Reported directly by Summit Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ClassOfWarrantOrRightOutstanding.

The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Summit Therapeutics's warrants and rights outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Summit Therapeutics's warrants and rights outstanding?: Summit Therapeutics (SMMT) reported warrants and rights outstanding of 0 in Q1 2026.
How has Summit Therapeutics's warrants and rights outstanding changed year-over-year?: Summit Therapeutics's warrants and rights outstanding decreased by 100.0% year-over-year, from 1M to 0.
What is the long-term trend for Summit Therapeutics's warrants and rights outstanding?: Over 2 years (2023 to 2025), Summit Therapeutics's warrants and rights outstanding has grown at a -100.0% compound annual growth rate (CAGR), from 5M to 0.